Effects of genetic polymorphism of CYP3A5 and UGT1A9 in brain-death donor and liver transplant recipients on pharmacokinetic profiles of tacrolimus and mycophenolate at steady state post-transplantatio
Phase 2
Recruiting
- Conditions
- Thai liver transplant patients (cadaveric liver transplant)Thai liver transplant patients (cadaveric liver transplant),CYP3A5 and UGT1A9 polymorphisms,Pharmacokinetics
- Registration Number
- TCTR20190707002
- Lead Sponsor
- Rachadapisek Sompote Fund.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Thai liver transplant patients (cadaveric liver transplant)
Aged 18 years or older
Exclusion Criteria
Thai liver transplant patients (Living liver transplant)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method